Zhixiang Wu
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 19, 2025
Integrative proteogenomic characterization of Wilms tumor.Cheng Cheng, Li Zhang, Xiaofeng Chang
|Mar 30, 2024
Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification.Xiaoxiao Hu, Yilu Zhou, Charlotte Hill
|Feb 25, 2022
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis.Xiaowei Liu, Yuanxia Cai, Cheng Cheng
|Aug 13, 2021
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor.Lijia Pan, Cheng Cheng, Peiwen Duan
|Jul 08, 2021
MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma.Yaoyao Gu, Xiaoxiao Hu, Xiaowei Liu
|Jul 17, 2020
Angiomatoid fibrous histiocytoma with Castleman disease: A case report.Yaoyao Gu, Fan Lv, Yeming Wu
Pageof 2
